PERIPHERAL BLOOD MONONUCLEAR DNA DAMAGE IDENTIFIED BY THE «СOMET» METHOD, AS A POSSIBLE INDICATOR OF SENSITIVITY OF MELANOMA TO IMMUNOTHERAPY WITH NIVOLUMAB
Purpose of the study: to assess whether the determination of the grade of dNA damage in the blood lymphocytes of patients with metastatic melanoma can be a criterion for assessing the effectiveness of therapy. Material and Methods. The grade of dNA damage in blood mononuclear cells was studied using...
Saved in:
Main Authors: | E. V. Tsyrlina, T. E. Poroshina, A. P. Oganesyan, S. A. Protsenko, L. M. Bershtein |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Russian Academy of Sciences, Tomsk National Research Medical Center
2021-05-01
|
Series: | Сибирский онкологический журнал |
Subjects: | |
Online Access: | https://www.siboncoj.ru/jour/article/view/1753 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
DNA damage in peripheral blood mononuclear cells in patients with melanoma
by: E. V. Tsyrlina, et al.
Published: (2022-06-01) -
Intestinal perforation after nivolumab immunotherapy for a malignant melanoma: a case report
by: Koji Yasuda, et al.
Published: (2017-08-01) -
A case of long-term survival treated with three metastasectomies and two subsequent adjuvant nivolumab therapies for recurrent malignant melanoma of the esophagus
by: Keita Hanada, et al.
Published: (2022-11-01) -
Multimodal therapy with surgery and adjuvant nivolumab for late-onset multiple liver metastases of choroidal malignant melanoma: a case report
by: Ryuta Muraki, et al.
Published: (2020-07-01) -
Nivolumab in real-life clinical practice
by: M. A. Lyadova, et al.
Published: (2019-12-01)